WC
ZBH icon

Wexford Capital’s Zimmer Biomet ZBH Stock Holding History

Wexford Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-17,779
Closed -$2.66M – 359
2020
Q4 		$2.66M Buy
+17,779
New +$2.51M 0.42% 61
2020
Q3 		– Sell
-24,315
Closed -$2.82M – 278
2020
Q2 		$2.82M Buy
+24,315
New +$2.8M 0.71% 35
2020
Q1 		– Sell
-96,623
Closed -$14M – 165
2019
Q4 		$14M Buy
+96,623
New +$13.3M 2.16% 10

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wexford Capital's ZBH Position: Q1 2021 in Review

Wexford Capital sold out of Zimmer Biomet (ZBH) in Q1 2021, closing a stake of 17,779 shares — an estimated $2.66M sold.

Wexford Capital first reported a position in ZBH in Q4 2019 and held it in 3 quarters. The position peaked at $14M in Q4 2019. 1,029 funds tracked by Wall St. Rank hold ZBH as of Q1 2021.

  • Wexford Capital reported no remaining Zimmer Biomet position as of Q1 2021 after selling out during the quarter.
  • Wexford Capital sold 17,779 Zimmer Biomet shares in Q1 2021, an estimated $2.66M.
  • Wexford Capital first reported a position in Zimmer Biomet in Q4 2019 and held it in 3 quarters.
  • Wexford Capital's Zimmer Biomet position peaked at $14M in Q4 2019.
  • 1,029 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2021.

Based on Wexford Capital's 13F filing for Q1 2021, filed 13 May 2021.